The import of insulin in dosage forms to Brazil is expected to show a steady increase from 702.25 thousand kilograms in 2024 to 752.68 thousand kilograms in 2028. These figures reflect the consistent forecast growth in demand for insulin in Brazil due to factors such as an increasing diabetic population and improvements in healthcare infrastructure. From 2024 to 2025, the projected growth is approximately 1.85%, while the annual increase from 2026 to 2027 is around 1.71%. Over the past five years, the compound annual growth rate (CAGR) indicates a sustained upward trend in imports.
Future trends to watch for include technological advancements in insulin products and the impact of local manufacturing on import needs. Market shifts due to healthcare policies and patient access initiatives will also play critical roles in shaping future import volumes. Furthermore, economic factors, such as exchange rate fluctuations, could influence import costs and decisions.
